Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles

Calcineurin inhibitors potentially prevent pro-allergic mediator release from basophils and mast cells but are rarely used systemically due to ubiquitous expressions of target signaling proteins. However, specific targeting of allergic effector cells with these inhibitors could circumvent unwanted s...

Full description

Bibliographic Details
Main Authors: Inna M. Yasinska, Luigi Calzolai, Ulrike Raap, Rohanah Hussain, Giuliano Siligardi, Vadim V. Sumbayev, Bernhard F. Gibbs
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00333/full
_version_ 1818173506216525824
author Inna M. Yasinska
Luigi Calzolai
Ulrike Raap
Rohanah Hussain
Giuliano Siligardi
Vadim V. Sumbayev
Bernhard F. Gibbs
Bernhard F. Gibbs
author_facet Inna M. Yasinska
Luigi Calzolai
Ulrike Raap
Rohanah Hussain
Giuliano Siligardi
Vadim V. Sumbayev
Bernhard F. Gibbs
Bernhard F. Gibbs
author_sort Inna M. Yasinska
collection DOAJ
description Calcineurin inhibitors potentially prevent pro-allergic mediator release from basophils and mast cells but are rarely used systemically due to ubiquitous expressions of target signaling proteins. However, specific targeting of allergic effector cells with these inhibitors could circumvent unwanted side effects. We recently demonstrated the biocompatibility of gold nanoparticles (AuNPs) as a platform for non-toxic delivery of signaling inhibitors due to unique physicochemical properties of these nanomaterials. Since AuNPs can be conjugated with both anti-allergic drugs and antibodies or other proteins that specifically recognize basophils and mast cells, our aims were to assess specific targeting of allergic effector cell function using AuNPs conjugated with the calcineurin inhibitor ascomycin. Purified human basophils and LAD2 human mast cells were used for investigations with AuNPs conjugated either to CD203c antibodies or containing stem cell factor (SCF), respectively, which were amine-coupled to acidic groups of reduced glutathione (GSH). GSH was also used as a spacer for immobilization of ascomycin on the gold surface. AuNPs conjugated with anti-CD203c and ascomycin strikingly blocked IgE-dependent degranulation of both purified basophils and those present in mixed leukocyte preparations, suggesting specific targeting of these cells. In contrast, LAD2 mast cell responses were not inhibited using anti-CD203c-containing nanoconjugates but were when the conjugates contained SCF. Successful targeting of allergic effector cells using gold nanoconjugates indicates that this technology may have therapeutic potential for the treatment of allergies by specifically delivering highly effective signaling inhibitors with reduced side effects.
first_indexed 2024-12-11T19:29:35Z
format Article
id doaj.art-3b65a95480b44f13895dedb94fdc3556
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T19:29:35Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-3b65a95480b44f13895dedb94fdc35562022-12-22T00:53:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-03-011010.3389/fphar.2019.00333441576Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold NanoparticlesInna M. Yasinska0Luigi Calzolai1Ulrike Raap2Rohanah Hussain3Giuliano Siligardi4Vadim V. Sumbayev5Bernhard F. Gibbs6Bernhard F. Gibbs7Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United KingdomEuropean Commission, Joint Research Centre, Ispra, ItalyDivision of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, GermanyBeamline B23, Diamond Light Source, Didcot, United KingdomBeamline B23, Diamond Light Source, Didcot, United KingdomMedway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United KingdomMedway School of Pharmacy, Universities of Kent and Greenwich, Chatham Maritime, United KingdomDivision of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, GermanyCalcineurin inhibitors potentially prevent pro-allergic mediator release from basophils and mast cells but are rarely used systemically due to ubiquitous expressions of target signaling proteins. However, specific targeting of allergic effector cells with these inhibitors could circumvent unwanted side effects. We recently demonstrated the biocompatibility of gold nanoparticles (AuNPs) as a platform for non-toxic delivery of signaling inhibitors due to unique physicochemical properties of these nanomaterials. Since AuNPs can be conjugated with both anti-allergic drugs and antibodies or other proteins that specifically recognize basophils and mast cells, our aims were to assess specific targeting of allergic effector cell function using AuNPs conjugated with the calcineurin inhibitor ascomycin. Purified human basophils and LAD2 human mast cells were used for investigations with AuNPs conjugated either to CD203c antibodies or containing stem cell factor (SCF), respectively, which were amine-coupled to acidic groups of reduced glutathione (GSH). GSH was also used as a spacer for immobilization of ascomycin on the gold surface. AuNPs conjugated with anti-CD203c and ascomycin strikingly blocked IgE-dependent degranulation of both purified basophils and those present in mixed leukocyte preparations, suggesting specific targeting of these cells. In contrast, LAD2 mast cell responses were not inhibited using anti-CD203c-containing nanoconjugates but were when the conjugates contained SCF. Successful targeting of allergic effector cells using gold nanoconjugates indicates that this technology may have therapeutic potential for the treatment of allergies by specifically delivering highly effective signaling inhibitors with reduced side effects.https://www.frontiersin.org/article/10.3389/fphar.2019.00333/fullgold nanoconjugatesbasophilsmast cellsascomycinIgECD203c
spellingShingle Inna M. Yasinska
Luigi Calzolai
Ulrike Raap
Rohanah Hussain
Giuliano Siligardi
Vadim V. Sumbayev
Bernhard F. Gibbs
Bernhard F. Gibbs
Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
Frontiers in Pharmacology
gold nanoconjugates
basophils
mast cells
ascomycin
IgE
CD203c
title Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
title_full Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
title_fullStr Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
title_full_unstemmed Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
title_short Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
title_sort targeting of basophil and mast cell pro allergic reactivity using functionalised gold nanoparticles
topic gold nanoconjugates
basophils
mast cells
ascomycin
IgE
CD203c
url https://www.frontiersin.org/article/10.3389/fphar.2019.00333/full
work_keys_str_mv AT innamyasinska targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT luigicalzolai targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT ulrikeraap targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT rohanahhussain targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT giulianosiligardi targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT vadimvsumbayev targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT bernhardfgibbs targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles
AT bernhardfgibbs targetingofbasophilandmastcellproallergicreactivityusingfunctionalisedgoldnanoparticles